US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. November 09, 2022

    Walgreens Faces $10B Opioid Trial Threat Despite $5B Deal

    New Mexico and Walgreens have submitted written closing arguments in the Land of Enchantment's opioid trial, and the state said it wants nearly $10 billion in damages — twice as much as Walgreens offered last week to settle opioid litigation across the entire country.

  2. November 04, 2022

    SF-Walgreens Opioid Trial Called Off Amid Settlement Talks

    Just days after Walgreens announced its $5 billion tentative settlement of nationwide opioid litigation, a California federal judge called off Monday's remedies trial in connection with an August decision that found the pharmacy giant liable for San Francisco's struggles with rampant opioid abuse.

  3. November 02, 2022

    After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'

    Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose business practices and legal defenses have received little attention, according to plaintiffs counsel and court records.

  4. November 02, 2022

    CVS, Walgreens Offer $10B To End Nationwide Opioid Suits

    CVS Pharmacy and Walgreens, the nation's two largest drugstore retailers, have preliminarily struck deals worth $10 billion to end thousands of lawsuits targeting their sales of prescription narcotics, the corporations and plaintiffs counsel said Wednesday.

  5. October 27, 2022

    Walgreens Says It'll Fight SF Estimate 40K Hooked On Opioids

    Walgreens will challenge a California federal judge's estimate that 40,000 San Franciscans suffered from opioid addiction, the retailer told the judge on Thursday ahead of a trial to determine what damages it owes for fueling the crisis, saying the number matters because the city wants it to pay billions for treatment.

  6. October 26, 2022

    SF Details $8B Opioid Plan As Walgreens Remedy Trial Looms

    San Francisco deserves $8 billion from Walgreens to alleviate the opioid epidemic's "calamitous effects," but it expects less money because the company created a problem it "cannot afford to fix," the city said Wednesday ahead of an imminent damages trial.

  7. October 26, 2022

    Pharmacies Win Temporary Freeze Of Ohio Opioid Injunction

    A federal judge on Wednesday gave CVS Pharmacy, Walgreens and Walmart a temporary reprieve from business practice requirements he imposed following a trial that found the pharmacy chains liable for problems associated with prescription painkiller addiction in two Ohio counties.

  8. October 18, 2022

    NM Opioid Case Against Walgreens 'Easy,' AG Says In Finale

    New Mexico's attorney general's office closed out an opioid bench trial against Walgreens on Tuesday with a declaration to the judge that the pharmacy giant has "made it easy for you with its admissions" at trial about how it distributed and dispensed the powerful narcotics.

  9. October 12, 2022

    Opioid Attys Stress 'Staggering' Costs In 6th Circ. Fee Feud

    Lead plaintiffs attorneys in multidistrict opioid litigation on Wednesday lambasted hundreds of local governments that are challenging a special fund for attorney fees, telling the Sixth Circuit that they've incurred "staggering" costs and that the challenge belongs in the dustbin.

  10. October 11, 2022

    Opioid Judge Won't Halt 'Waste Of Time' Ohio Trial

    A Cleveland federal judge overseeing thousands of lawsuits against drug companies said Tuesday that he would not halt trial preparations involving a southwestern Ohio county and several major pharmacy chains while the Sixth Circuit reviews the legal theory that led to a $650 million verdict in a similar case.